Petros Grivas

53PUBLICATIONS
400CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|Oct 02, 2026
Prevalence of PD-L1-High Tumor Expression and Association with First-Line Treatment Outcomes in Patients with Metastatic Urothelial Carcinoma: Results from a Prospective Observational Cohort Study.

|Sep 16, 2026
Evolution and heterogeneity of lethal metastatic bladder cancer subtypes.

|Aug 18, 2026
Longitudinal Phenotyping of Circulating Tumor Cells using a Scalable Deep Learning Framework.

|Jul 30, 2026
Clinical toxicity of ADCs and ICI-ADC combinations: mechanisms, patterns and management.

|Mar 31, 2026
PSMA PET/CT-derived Tumor Volume for Predicting Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving 177Lu-PSMA-617.

Alireza Ghodsi, Lukas Owens, Ridvan Arda Demirci

|Jan 16, 2026
Steroid-sparing strategies for managing immune-related adverse events.

Jennifer J Huang, Maryam YousefiAsl, Namrata Singh

Pageof 9

Frequent Collaborators

7 joint publications

Andrea Necchi

7 joint publications

Cora N Sternberg

6 joint publications

Scott Tagawa

6 joint publications

Ali Raza Khaki